Kering saw the highest growth of 0.99% in patent filings and 1.99% in grants in April in Q2 2024. Compared to Q1 2024, Q2 2024 saw an increase in patent filings by 0.99% and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Kering‘s patent filings and grants. Buy the databook here.
Kering has been focused on protecting inventions in United States(US) with 18 publications in Q2 2024
The United States(US) Patent Office dominates the patent filings and grants with nearly 50% filings and 89% grants. The United States(US), Hungary(HU), Canada(CA), and Spain(ES) patent Office are among the top ten patent offices where Kering is filings its patents. Among the top granted patent authorities, Kering has 89% of its grants in United States(US), 5% in Canada(CA) and 5% in Spain(ES).
EssilorLuxottica and Magic Leap could be the strongest competitors for Kering
In terms of grant share, Kering stands first among its competitors followed by EssilorLuxottica and Magic Leap.
Patents related to health & wellness lead Kering's portfolio
Kering has the highest number of patents in health & wellness. For health & wellness, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Breast cancer related patents lead Kering portfolio followed by coronavirus disease 2019 (covid-19), and depression
Kering has highest number of patents in breast cancer followed by coronavirus disease 2019 (covid-19), depression, schizophrenia, and hyperalgesia.
For comprehensive analysis of Kering's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.